Notch3 drives meningioma tumorigenesis and resistance to radiotherapy
收藏NIAID Data Ecosystem2026-05-02 收录
官方服务：
资源简介：
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景：
创建时间：
2024-08-02
相关数据集
DataSheet_1_Insight of a Metabolic Prognostic Model to Identify Tumor Environment and Drug Vulnerability for Lung Adenocarcinoma.pdf
Metabolic reprogramming is a novel method for the treatment of malignant tumors. The exploration of metabolism procedures between radiosensitive and radioresistant tumors may provide novel perspective
NIAID Data Ecosystem100
Table_2_PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells.xlsx
Treatment-resistant glioma stem cells are thought to propagate and drive growth of malignant gliomas, but their markers and our ability to target them specifically are not well understood. We demonstr
NIAID Data Ecosystem50
FIBP interacts with transcriptional factor STAT3 to induce Eme1 expression and drives radioresistance in lung cancer
Background: Cancer cells inevitably develop resistance to radiation in lung cancer radiotherapy. However, the underlying mechanisms remain to be fully clarified. This study aimed to explore the roles
NIAID Data Ecosystem50
Table_1_FSCN1 Promotes Radiation Resistance in Patients With PIK3CA Gene Alteration.docx
Radiotherapy is one of the standard treatments for cervical cancer and head and neck cancer. However, the clinical efficacy of this treatment is limited by radioresistance. The discovery of effective
NIAID Data Ecosystem100
Additional file 2 of ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells
Additional file 2: Table S1. Correlation analysis of ARPC1B with PN and MES marker genes (Correlation). Table S2. Mass spectrometry result of proteins related with ARPC1B. Table S3. The correlation be
NIAID Data Ecosystem50
